GlassScriptPhysician profile
Tao Xie
NPI 1417132119
$10,399.47
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,162 · 2021: $12.29 · 2022: $2,225.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ge Healthcare | $6,012.00 | 2019 | |
| Acadia Pharmaceuticals INC | $2,200.00 | 2022 | |
| H. Lundbeck A S | $2,018.91 | 2019 | |
| Boston Scientific Corporation | $131.46 | 2019 | |
| Abbvie INC. | $24.81 | 2022 | |
| Supernus Pharmaceuticals, INC. | $12.29 | 2021 |
3 companies reported research payments only; those appear in the research section below.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tao Xie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.